1. Barta SK, Lee SY, Kaplan LD, Noy A, Sparano JA. Pooled analysis of AMC trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin’s lymphoma. Cancer. 2012;118(16):3977–83.
2. Corona G, Vaccher E, Cattarossi G, Sartor I, Toffoli G. Potential hazard of pharmacokinetic interaction between lopinavir-ritonavir protease inhibitor and irinotecan. AIDS. 2005;19(17):2043–4.
3. Hymes KB, Cheung T, Greene JB, Prose NS, Marcus A, Ballard H, William DC, Laubenstein W. Kaposi’s sarcoma in homosexual men – a report of 8 cases. Lancet. 1981;2(8248):688.
4. Kaplan LD, Kahn JO, Crowe S, et al. Clinical and viral effects of recombinant GM-CSF in patients receiving chemotherapy for HIV-associated non-Hodgkin’s lymphoma: results of a randomized trial. J Clin Oncol. 1994;9(6):929–40.
5. Kaplan LD, Straus DU, Testa MA, et al. Low-dose compared to high dose m-BACOD chemotherapy for non-Hodgkin’s lymphoma associated with HIV: NIAID ACTG Trial. N Engl J Med. 1997;336(23):1641–8.